scPharmaceuticals Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 13.81 million compared to USD 9.25 million a year ago. Basic loss per share from continuing operations was USD 0.35 compared to USD 0.3 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.605 USD | +2.56% | +1.09% | -26.32% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.32% | 162M | |
+25.88% | 661B | |
+26.74% | 566B | |
-6.64% | 352B | |
+19.53% | 332B | |
+3.48% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.60% | 145B |
- Stock Market
- Equities
- SCPH Stock
- News scPharmaceuticals Inc.
- ScPharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023